These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 25523883)

  • 81. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.
    Lopresti AL; Drummond PD
    J Affect Disord; 2017 Jan; 207():188-196. PubMed ID: 27723543
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials.
    Al-Karawi D; Al Mamoori DA; Tayyar Y
    Phytother Res; 2016 Feb; 30(2):175-83. PubMed ID: 26610378
    [TBL] [Abstract][Full Text] [Related]  

  • 83. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial.
    Esmaily H; Sahebkar A; Iranshahi M; Ganjali S; Mohammadi A; Ferns G; Ghayour-Mobarhan M
    Chin J Integr Med; 2015 May; 21(5):332-8. PubMed ID: 25776839
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical Use of Curcumin in Depression: A Meta-Analysis.
    Ng QX; Koh SSH; Chan HW; Ho CYX
    J Am Med Dir Assoc; 2017 Jun; 18(6):503-508. PubMed ID: 28236605
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Plant-derived natural medicines for the management of depression: an overview of mechanisms of action.
    Farahani MS; Bahramsoltani R; Farzaei MH; Abdollahi M; Rahimi R
    Rev Neurosci; 2015; 26(3):305-21. PubMed ID: 25719303
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings.
    Kaufmann FN; Gazal M; Bastos CR; Kaster MP; Ghisleni G
    Eur J Pharmacol; 2016 Aug; 784():192-8. PubMed ID: 27235294
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders.
    Wu A; Noble EE; Tyagi E; Ying Z; Zhuang Y; Gomez-Pinilla F
    Biochim Biophys Acta; 2015 May; 1852(5):951-61. PubMed ID: 25550171
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Curcumin attenuates severity of premenstrual syndrome symptoms: A randomized, double-blind, placebo-controlled trial.
    Khayat S; Fanaei H; Kheirkhah M; Moghadam ZB; Kasaeian A; Javadimehr M
    Complement Ther Med; 2015 Jun; 23(3):318-24. PubMed ID: 26051565
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis.
    Panahi Y; Hosseini MS; Khalili N; Naimi E; Majeed M; Sahebkar A
    Clin Nutr; 2015 Dec; 34(6):1101-8. PubMed ID: 25618800
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health.
    Kocaadam B; Şanlier N
    Crit Rev Food Sci Nutr; 2017 Sep; 57(13):2889-2895. PubMed ID: 26528921
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.
    Shoba G; Joy D; Joseph T; Majeed M; Rajendran R; Srinivas PS
    Planta Med; 1998 May; 64(4):353-6. PubMed ID: 9619120
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?
    Trebatická J; Ďuračková Z
    Oxid Med Cell Longev; 2015; 2015():248529. PubMed ID: 26180581
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
    Remington R; Bechtel C; Larsen D; Samar A; Doshanjh L; Fishman P; Luo Y; Smyers K; Page R; Morrell C; Shea TB
    J Alzheimers Dis; 2015; 45(2):395-405. PubMed ID: 25589719
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.
    Mao JJ; Xie SX; Zee J; Soeller I; Li QS; Rockwell K; Amsterdam JD
    Phytomedicine; 2015 Mar; 22(3):394-9. PubMed ID: 25837277
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies.
    Lopresti AL
    J Psychopharmacol; 2017 Mar; 31(3):287-302. PubMed ID: 28135888
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Curcumin supplementation likely attenuates delayed onset muscle soreness (DOMS).
    Nicol LM; Rowlands DS; Fazakerly R; Kellett J
    Eur J Appl Physiol; 2015 Aug; 115(8):1769-77. PubMed ID: 25795285
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis.
    Ilieva IP; Hook CJ; Farah MJ
    J Cogn Neurosci; 2015 Jun; 27(6):1069-89. PubMed ID: 25591060
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults.
    Rainey-Smith SR; Brown BM; Sohrabi HR; Shah T; Goozee KG; Gupta VB; Martins RN
    Br J Nutr; 2016 Jun; 115(12):2106-13. PubMed ID: 27102361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.